Ofloxacin versus doxycycline in gynecological infections.
40 patients were investigated with either ofloxacin (2 X 20 mg/7d) or doxycycline (2 X 100 mg/7d). E. coli (28 from 61 strains) was the predominant strain isolated. Microbiological efficacy: 51 from 61 strains were eliminated: 29 from 32 strains in the ofloxacin group and 22 from 29 strains in the doxycycline group. Two patients in the ofloxacin and four in the doxycycline group were not cured. There were two side effects (sickness) in the doxycycline and two in the ofloxacin group.
D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D004318:Doxycycline / Q000627:therapeutic use*; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D015242:Ofloxacin; D010078:Oxazines / Q000627:therapeutic use*
D000890:Anti-Infective Agents; D010078:Oxazines; D015242:Ofloxacin; D004318:Doxycycline